Interactions between pharmaceutical companies and healthcare professionals (HCPs) and healthcare organizations (HCOs) have a profound and positive influence on the quality of patient treatments and value of future research.
To ensure that the interactions meet the high integrity standards that patients, governments and other stakeholders expect, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its member associations and companies have adopted codes and guidelines.
The EFPIA Disclosure Code was created to foster greater transparency and build greater trust between the pharmaceutical industry, the medical community and wider society.
As an EFPIA-member Merck is fully committed to the efforts of strengthening these relationships and to protect their integrity. Therefore the company documents and discloses all Transfers of Value to Healthcare Professionals, and Healthcare Organizations as well as Transfers of Value arising out of Research and Development (R&D) activities in every EFPIA country where Merck operates.
Disclosure is made on an annual basis and the reporting period covers a full calendar year. First reporting period is the year 2015.